Introduction Executive Summary Vitiligo: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Vitiligo – DelveInsight’s Analytical Perspective In-depth Commercial Assessment • Vitiligo companies’ collaborations, Licensing, Acquisition -Deal Value Trends Vitiligo Collaboration Deals • Company-Company Collaborations (Licensing / Partnering) Analysis • Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) • Comparative Analysis Ruxolitinib: Incyte Corporation • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis PF-06651600: Pfizer • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis AC-1101: TWi Biotechnology • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical/Discovery Stage Products • Comparative Analysis QLT-450: Dermira • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Vitiligo Key Companies Vitiligo Key Products Vitiligo- Unmet Needs Vitiligo- Market Drivers and Barriers Vitiligo- Future Perspectives and Conclusion Vitiligo Analyst Views Vitiligo Key Companies Appendix

Table 1 Total Products for Vitiligo Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Incyte Corporation • Amgen • Boston Pharmaceuticals • Arcutis Biotherapeutics • Pfizer • Dermavant Sciences • Clinuvel Pharmaceuticals • Celgene • TWi Biotechnology • AXIM Biotechnologies • Arrien Pharmaceuticals • Dermira